XWELL (XWEL) Registration filing summary
Event summary combining transcript, slides, and related documents.
Registration filing summary
1 Apr, 2026Company overview and business model
Operates as a global wellness organization with three segments: XpresSpa (airport spa services), XpresTest (bio-surveillance and testing), and Naples Wax Center (hair removal and skincare).
Expanded internationally with spa locations in the UAE, Netherlands, and Turkey, and is pursuing further international growth.
Transitioned from COVID-19 testing to bio-surveillance in partnership with the CDC, securing multi-year contracts.
Acquired Naples Wax Center to diversify beyond airport-based services and scale the wellness platform.
Financial performance and metrics
XpresTest secured a three-year CDC contract with a base value of $22.2 million and a maximum of $24.8 million.
Naples Wax Center was acquired for $1.624 million to support long-term financial goals.
Use of proceeds and capital allocation
Will not receive proceeds from resale of shares by selling stockholders; proceeds from warrant exercises, if any, will be used for general corporate purposes.
Latest events from XWELL
- 2025 revenue hit $29.2M, with cost reductions and new capital fueling expansion and innovation.XWEL
Q4 20251 Apr 2026 - Board recommends approval of all annual meeting proposals, including reverse split and share issuance.XWEL
Proxy Filing3 Feb 2026 - Annual meeting to vote on directors, auditor, executive pay, and tax asset protection plan.XWEL
Proxy Filing3 Feb 2026 - Board recommends voting for all proposals, including director elections and tax asset protection.XWEL
Proxy Filing3 Feb 2026 - Stockholders to vote on equity issuance, board structure, plan amendments, and auditor ratification.XWEL
Proxy Filing3 Feb 2026 - Registering 1,051,677 shares for resale may cause significant dilution to existing stockholders.XWEL
Registration Filing3 Feb 2026 - Registration of 32.7M shares may cause major dilution as the company expands wellness services.XWEL
Registration Filing3 Feb 2026 - Registration of 62M shares for resale may cause major dilution amid expansion and new contracts.XWEL
Registration Filing3 Feb 2026 - Virtual annual meeting to vote on directors, auditor, compensation, board structure, and stock split.XWEL
Proxy Filing3 Feb 2026